Formation of amyloid fibrils by bovine carbonic anhydrase

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1784, Issue 6, 2008, Pages 930-935

  Rana, Anshul ^a   Gupta, Teemish Praveen ^a   Bansal, Saurabh ^a   Kundu, Bishwajit ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

Aggregation; Amyloidogenesis; Bovine carbonic anhydrase; Recurrence quantification analysis

Indexed keywords

AMYLOID; CARBONATE DEHYDRATASE; CONGO RED; GLOBULAR PROTEIN; POLYPEPTIDE; THIOFLAVINE;

ARTICLE; BETA SHEET; CIRCULAR DICHROISM; COW; FLUORESCENCE MICROSCOPY; IN VIVO STUDY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID; ANIMALS; CARBONIC ANHYDRASE II; CATTLE; CIRCULAR DICHROISM; CONGO RED; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; PROTEIN FOLDING; THIAZOLES;

BOVINAE;

EID: 43649090986     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2008.02.020     Document Type: Article

References (54)

1. Dobson C.M. Principles of protein folding misfolding and aggregation. Sem. Cell Dev. Biol. 15 (2004) 3-16
2. Thomas P.J., Qu B.H., and Pedersen P.L. Defective protein folding as a basis of human disease. Trends Biochem. Sci. 20 (1995) 456-459
3. Dobson C.M. The structural basis of protein folding and its links with human disease. Phil. Trans. R. Soc. London Ser. B 356 (2001) 133-145
4. Tan S.Y., and Pepys M.B. Amyloidosis. Histopathology 25 (1994) 403-414
5. Koo Jr. E.H., Lansbury P.T., and Kelly J.W. Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9989-9990
6. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75 (2006) 333-366
7. Kelly J.W. Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6 (1996) 11-17
8. Sunde M., and Blake C.C.F. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein. Chem. 50 (1997) 123-159
9. Dobson C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24 (1999) 329-332
10. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., and Dobson C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 3590-3594
11. Westermark P., Benson M.D., Buxbaum J.N., Cohen A.S., Frangione B., Ikeda S., Masters C.L., Merlini G., Saraiva M.J., and Sipe J.D. Nomenclature Committee of the International Society of Amyloidosis Amyloid: toward terminology clarification. Amyloid 12 (2005) 1-4
12. Kisilevsky R. Amyloid and amyloidoses: differences, common themes, and practical considerations. Mod. Path. 4 (1991) 514-518
13. Sunde M., Serpell L.C., Bartlam M., Fraser P.E., Pepys M.B., and Blake C.C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273 (1997) 729-739
14. Miranker A.D. Unzipping the mysteries of amyloid fiber formation. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4335-4336
15. Fandrich M. Absolute correlation between lag time and growth rate in the spontaneous formation of several amyloid-like aggregates and fibrils. J. Mol. Biol. 365 (2007) 1266-1270
16. Rochet J.C., and T Lansbury P. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10 (2000) 60-68
17. Kelly J.W. Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6 (1996) 11-17
18. Kelly J.W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8 (1998) 101-106
19. Collins S.R., Douglass A., Vale R.D., and Weissman J.S. Mechanism of prion propagation: Amyloid growth occurs by monomer addition. PLoS Biol. 2 (2004) e321
20. Kreplak L., and Aebi U. From the polymorphism of amyloid fibrils to their assembly mechanism and cytotoxicity. Adv. Protein Chem. 73 (2006) 217-233
21. Guo Z., and Eisenberg D. Runaway domain swapping in amyloid-like fibrils of T7 endonuclease. Proc. Natl. Acad. Sci. U. S. A. 23 (2006) 8042-8047
22. Bertoncini C.W., Jung Y.S., Fernandez C.O., Hover W., Griesinger C., Jovin T.M., and Zweckstetter M. Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1430-1435
23. Bertoncini C.W., Fernandez C.O., Griesinger C., Jovin T.M., and Zweckstetter M. Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation. J. Biol. Chem. 280 (2005) 30649-30652
24. Goldberg M.S., and Lansbury Jr. P.T. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?. Nat. Cell Biol. 2 (2000) E115-E119
25. Palecek E., Ostatna V., Masarik M., Bertoncini C.W., and Jovin T.M. Changes in interfacial properties of alpha-synuclein preceeding its aggregation. Analyst 133 (2008) 76-84
26. Heise H. Solid state NMR spectroscopy of amyloid proteins. ChemBioChem 9 (2008) 179-189
27. Thompson K. Unraveling the secrets of Alzheimer's beta-amyloid fibrils. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 383-385
28. Caflisch L.A. Computational models for the prediction of polypeptide aggregation propensity. Curr. Opin. Chem. Biol. 10 (2006) 437-444
29. Dodgson S.J. The Carbonic Anhydrases; Cellular Physiology and Molecular Genetics (1991), Plenum Press, New York
30. Chegwidden W.R., Carter N.D., and Edwards Y.H. The Carbonic Anhydrases: New Horizons (2000), Birkhauser, Basel
31. Donaldson T.L., and Quinn J.A. Kinetic constants determined from membrane transport measurements: carbonic anhydrase activity at high concentrations. Proc. Natl. Acad. Sci. U. S. A. 71 (1974) 4995-4999
32. Wong K.P., and Tanford C. Denaturation of bovine carbonic anhydrase B by guanidine hydrochloride: a process involving separable sequential conformational transitions. J. Biol. Chem. 248 (1973) 8518-8523
33. Lindskog S. Structure and mechanism of carbonic anhydrase. Pharmacol. Ther. 74 (1997) 1-20
34. Saito R., Sato T., Atsushi I., and Tanaka N. Structure of bovine carbonic anhydrase II at 1.95 A resolution. Acta Crystallogr. Sect. D: Biol. Crystallogr. 60 (2004) 792-795
35. Grover A., Dugar A., and Kundu B. Predicting alternate structure attainment and amyloidogenesis: a nonlinear signal analysis approach. Biochem. Biophys. Res. Commun. 338 (2005) 1410-1416
36. Kundu B., and Guptasarma P. Use of a hydrophobic dye to indirectly probe the structural organization and conformational plasticity of molecules in amorphous aggregates of carbonic anhydrase. Biochem. Biophys. Res. Commun. 293 (2002) 572-577
37. Zbilut J.P., Giuliani A., Webber Jr. C.L., and Colosimo A. Recurrence quantification analysis in structure-function relationships of proteins: an overview of a general methodology applied to the case of TEM-1 β-lactamase. Protein Eng. 11 (1998) 87-93
38. Freskgird P.O., Carlsson U., Miirtensson L.G., and Jonsson B.H. Folding around the C-terminus of human carbonic anhydrase II. Kinetic characterization by use of a chemically reactive W-group introduced by protein engineering. FEBS lett. 289 (1991) 117-122
39. Eisert R., Felau L., and Brown L.R. Methods for enhancing the accuracy and reproducibility of Congo red and thioflavin T assays. Anal. Biochem. 353 (2006) 144-146
40. Colon W., and Kelly J.W. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31 (1992) 8654-8660
41. Uversky V.N., and Ptitsyn O.B. Further evidence on the equilibrium ''pre-molten globule state'': four-state guanidinium chloride-induced unfolding of carbonic anhydrase B at low temperature. J. Mol. Biol. 255 (1996) 215-218
42. Dolgikh D.A., Kolomiets A.P., Bolotina I.A., and Ptitsyn O.B. Molten-globule state accumulates in carbonic anhydrase folding. FEBS Lett. 165 (1984) 88-92
43. Gross M., Wilkins D.K., Pitkeathly M.C., Chung E.W., Higham C., Clark A., and Dobson C.M. Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB. Protein Sci. 8 (1999) 1350-1357
44. Frida P., Anisimova S.V., and Popovic N. Congo red and protein aggregation in neurodegenerative diseases, Brain Research Reviews. Brain Res. Rev. 53 (2007) 135-160
45. Ban T., Hamada D., Hasegawa K., Naiki H., and Goto Y. Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence. J. Biol. Chem. 278 (2003) 16462-16465
46. Moore R.A., Hayes H.F., Fischer E.R., and Priola S.A. Amyloid formation via supramolecular peptide assemblies. Biochemistry 46 (2007) 7079-7087
47. Mishima T., Ohkuri T., Monji A., Imoto T., and Ueda T. A particular hydrophobic cluster in the residual structure of reduced lysozyme drastically affects the amyloid fibril formation. Biochem. Biophys. Res. Commun. 356 (2007) 769-772
48. Kundu B., Maiti N.R., Jones E.M., Surewicz K.A., Vanik D.L., and Surewicz W.K. Nucleation dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12069-12074
49. Butko P., Buford J.P., Goodwin J.S., Stroud P.A., McCormick C.L., and Cannon C.G. Spectroscopic evidence for amyloid-like interfacial self-assembly of hydrophobin Sc3. Biochem. Biophys. Res. Commun. 280 (2001) 212-215
50. Smith A.M., Jahn T.R., Ashcroft A.E., and Radford S.E. Direct observation of oligomeric species formed in the early stages of amyloid fibril formation using electrospray ionisation mass spectrometry. J. Mol. Biol. 364 (2006) 9-19
51. Iwata K., Matsuura T., Sakurai K., Nakagawa A., and Goto Y. High-resolution crystal structure of beta2-microglobulin formed at pH 7.0. J. Biochem. 142 (2007) 413-419
52. Conway K.A., Harper J.D., and Lansbury P.T. Accelerated in-vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson's disease. Nat. Med. 4 (1998) 1318-1320
53. Richardson J.S., and Richardson D.C. Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2754-2759
54. Xiong L.W., Raymond L.D., Hayes S.F., Raymond G.J., and Caughey B. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein. J. Neurochem. 79 (2001) 669-678